Paper3290520
Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.
Corpier CL and 6 others. JAMA, 1988. Cited by 243 papers, by iCite.
Cite this record
ConductScience Library. Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. Papers, record 3290520. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3290520
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Hypercholesterolemia | Major topic |
| Lovastatin | Major topic |
| Rhabdomyolysis | Major topic |
| Adult | |
| Creatine Kinase | |
| Heart Transplantation | |
| Humans | |
| Legionellosis | |
| Male | |
| Middle Aged |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39545952 | Towards streamlined product information: reporting of transporter-mediated drug interactions. | Eur J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/39545952 | PubMed |
| 37688635 | Performance and mechanism of co-culture of Monascus purpureus, Lacticaseibacillus casei, and Saccharomyces cerevisiae to enhance lovastatin production and lipid-lowering effects. | Bioprocess Biosyst Eng | 2023 | https://conductscience.org/library/papers/37688635 | PubMed |
| 29389579 | A randomized, double-blind clinical study of the effects of Ankascin 568 plus on blood lipid regulation. | J Food Drug Anal | 2018 | https://conductscience.org/library/papers/29389579 | PubMed |
| 29204172 | Protective effects of coenzyme Q10 and L-carnitine against statin-induced pancreatic mitochondrial toxicity in rats. | Res Pharm Sci | 2017 | https://conductscience.org/library/papers/29204172 | PubMed |
| 24700094 | Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy. | World J Surg | 2014 | https://conductscience.org/library/papers/24700094 | PubMed |
| 19159124 | Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. | Am J Cardiovasc Drugs | 2008 | https://conductscience.org/library/papers/19159124 | PubMed |
| 16722833 | Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes. | Br J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16722833 | PubMed |
| 15139786 | Management of hyperlipidaemia associated with heart transplantation. | Drugs | 2004 | https://conductscience.org/library/papers/15139786 | PubMed |
| 14531725 | Clinical pharmacokinetics of atorvastatin. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/14531725 | PubMed |
| 12495360 | Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant? | Drug Saf | 2003 | https://conductscience.org/library/papers/12495360 | PubMed |
| 12036392 | Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. | Clin Pharmacokinet | 2002 | https://conductscience.org/library/papers/12036392 | PubMed |
| 11599634 | How well tolerated are lipid-lowering drugs? | Drugs Aging | 2001 | https://conductscience.org/library/papers/11599634 | PubMed |
| 11259986 | The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11259986 | PubMed |
| 11122720 | Does differing metabolism by cytochrome p450 have clinical importance? | Curr Atheroscler Rep | 2000 | https://conductscience.org/library/papers/11122720 | PubMed |
| 10668858 | Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10668858 | PubMed |
| 9929751 | Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia. | Clin Cardiol | 1999 | https://conductscience.org/library/papers/9929751 | PubMed |
| 9515185 | Clinical pharmacokinetics of fibric acid derivatives (fibrates). | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9515185 | PubMed |
| 9160173 | Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9160173 | PubMed |
| 9118815 | Choosing the right lipid-regulating agent. A guide to selection. | Drugs | 1996 | https://conductscience.org/library/papers/9118815 | PubMed |
| 8521762 | Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia. | Drugs | 1995 | https://conductscience.org/library/papers/8521762 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3290520
GET https://conductscience.org/api/papers/v1/3290520/cited_by?page=2